Publications by authors named "Josef Scheiber"

Claim this Profile
S
Sex-specific response of the human plasma lipidome to short-term cold exposure.
Marcus Höring, Sarah Brunner, Josef Scheiber, Julius Honecker, Gerhard Liebisch

Biochim Biophys Acta Mol Cell Biol Lipids· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial lipidomes are tissue specific - low cholesterol contents relate to UCP1 activity.
Sarah Brunner, Marcus Höring, Gerhard Liebisch, Sabine Schweizer, Josef Scheiber

Life Sci Alliance· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the predictive value of BDNF -87 methylation for antidepressant treatment success in severely depressed patients-a randomized rater-blinded trial.
Hannah Benedictine Maier, Alexandra Neyazi, Gabriel L Bundies, Fiona Meyer-Bockenkamp, Stefan Bleich, Josef Scheiber

Trials· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omics and Artificial Intelligence in Kidney Diseases.
Nadja Grobe, Josef Scheiber, Hanjie Zhang, Christian Garbe, Xiaoling Wang

Adv Kidney Dis Health· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma.
Louisa Hempel, Constantin Lapa, Alexander Dierks, Andreas Gaumann, Josef Scheiber

Ther Adv Med Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare SARS-CoV-2 antibody development in cancer patients.
Louisa Hempel, Jakob Molnar, Sebastian Robert, Julia Veloso, Zeljka Trepotec, Josef Scheiber

Semin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 infections in cancer outpatients-Most infected patients are asymptomatic carriers without impact on chemotherapy.
Louisa Hempel, Armin Piehler, Michael W Pfaffl, Jakob Molnar, Benedikt Kirchner, Josef Scheiber

Cancer Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
xMaP-An Interpretable Alignment-Free Four-Dimensional Quantitative Structure-Activity Relationship Technique Based on Molecular Surface Properties and Conformer Ensembles.
Jan Dreher, Josef Scheiber, Nikolaus Stiefl, Knut Baumann

J Chem Inf Model· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Backtranslating clinical knowledge for use in cheminformatics--what is the potential?
Josef Scheiber

Bioorg Med Chem· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How can we enable drug discovery informatics for personalized healthcare?
Josef Scheiber

Expert Opin Drug Discov· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases.
Vildan Alptüzün, Michaela Prinz, Verena Hörr, Josef Scheiber, Krzysztof Radacki

Bioorg Med Chem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemogenomic analysis of safety profiling data.
Josef Scheiber, Jeremy L Jenkins

Methods Mol Biol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
Sai Chetan K Sukuru, Jeremy L Jenkins, Rohan E J Beckwith, Josef Scheiber, Andreas Bender

J Biomol Screen· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of ligand based models for protein domains to predict novel molecular targets and applications to triage affinity chromatography data.
Andreas Bender, Dmitri Mikhailov, Meir Glick, Josef Scheiber, John W Davies

J Proteome Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping adverse drug reactions in chemical space.
Josef Scheiber, Jeremy L Jenkins, Sai Chetan K Sukuru, Andreas Bender, Dmitri Mikhailov

J Med Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis.
Josef Scheiber, Bin Chen, Mariusz Milik, Sai Chetan K Sukuru, Andreas Bender

J Chem Inf Model· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How similar are similarity searching methods? A principal component analysis of molecular descriptor space.
Andreas Bender, Jeremy L Jenkins, Josef Scheiber, Sai Chetan K Sukuru, Meir Glick

J Chem Inf Model· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which aspects of HTS are empirically correlated with downstream success?
Andreas Bender, Dejan Bojanic, John W Davies, Thomas J Crisman, Dmitri Mikhailov, Josef Scheiber

Curr Opin Drug Discov Devel· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Virtual fragment linking": an approach to identify potent binders from low affinity fragment hits.
Thomas J Crisman, Andreas Bender, Mariusz Milik, Jeremy L Jenkins, Josef Scheiber

J Med Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2.
Björn Degel, Peter Staib, Sebastian Rohrer, Josef Scheiber, Erika Martina

ChemMedChem· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding false positives in reporter gene assays: in silico chemogenomics approaches to prioritize cell-based HTS data.
Thomas J Crisman, Christian N Parker, Jeremy L Jenkins, Josef Scheiber, Mathis Thoma

J Chem Inf Model· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
Andreas Bender, Josef Scheiber, Meir Glick, John W Davies, Kamal Azzaoui

ChemMedChem· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting acetylcholinesterase to treat neurodegeneration.
Ulrike Holzgrabe, Petra Kapková, Vildan Alptüzün, Josef Scheiber, Eva Kugelmann

Expert Opin Ther Targets· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aziridide-based inhibitors of cathepsin L: synthesis, inhibition activity, and docking studies.
Radim Vicik, Matthias Busemann, Christoph Gelhaus, Nikolaus Stiefl, Josef Scheiber

ChemMedChem· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Charge interactions do the job: a combined statistical and combinatorial approach to finding artificial receptors for binding tetrapeptides in water.
Carsten Schmuck, Martin Heil, Josef Scheiber, Knut Baumann

Angew Chem Int Ed Engl· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis